|  | All participants | All non-routine recommendations | Disease-specific non-routine recommendations |
---|---|---|---|---|
Breast Cancer∞ |  |  |  |  |
 | Risk of breast cancer | 48 (22.8%) | 29 (23.2%) | 18 (32.7%) |
 | Mammography | 125 (59.2%) | 68 (54.4%) | 33 (60.0%) |
 | Breast MRI | 10 (4.7%) | 8 (6.4%) | 5 (9.1%) |
 | Tamoxifen | 6 (2.8%) | 5 (4%) | 4 (7.3%) |
Ovarian Cancer∞ |  | 19 (9.0%) | 13 (10.4%) | 6 (50%) |
Colon cancer* | Â | Â | Â | Â |
 | Risk of colon cancer | 113 (30.5%) | 50 (29.2%) | 39 (34.8%) |
 | Screening for colon cancer | 260 (70.3%) | 118 (69.0%) | 83 (74.1%) |
Thrombosis* | Â | 35 (9.5%) | 18 (10.5%) | 10 (41.7%) |
Seeing a specialist* | Â | 82 (22.2%) | 62 (36.3%) | n/a |
Lifestyle choices* | Â | 192 (51.9%) | 83 (48.5%) | n/a |